Literature DB >> 3025001

Effects of memantine on the frog neuromuscular junction.

K Masuo, K Enomoto, T Maeno.   

Abstract

The effects of memantine, an adamantane derivative, on neuromuscular transmission in the frog sartorius muscle preparation were studied by measuring the endplate current (EPC) by the voltage clamp method. Memantine (0.5-50 microM) reduced the peak amplitude and shortened the duration of the EPC, and the membrane voltage-peak EPC relationship became non-linear. Since it decreased the quantal height of the EPC without affecting the mean quantal content, the effects were considered to be mainly postsynaptic. Noise analysis revealed that memantine decreased the mean lifetime of the ACh-activated channel. In addition, lineweaver-Burk analysis of the response to ionophoretically applied carbamylcholine showed that memantine acted essentially as a linear mixed-type inhibitor. Thus memantine seems to block neuromuscular transmission by reacting with the ACh receptor-ion channel complex in both the open and closed states.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3025001     DOI: 10.1016/0014-2999(86)90267-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

Review 1.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

2.  Protection of DFP-induced oxidative damage and neurodegeneration by antioxidants and NMDA receptor antagonist.

Authors:  Snjezana Zaja-Milatovic; Ramesh C Gupta; Michael Aschner; Dejan Milatovic
Journal:  Toxicol Appl Pharmacol       Date:  2009-07-14       Impact factor: 4.219

3.  Energy metabolism of the equine cumulus oocyte complex during in vitro maturation.

Authors:  N Lewis; K Hinrichs; H J Leese; C McG Argo; D R Brison; R Sturmey
Journal:  Sci Rep       Date:  2020-02-26       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.